Where Novartis Pharmaceuticals Corporation Funded Research Is Published: Top 20 Journals

In shortNovartis Pharmaceuticals Corporation (Switzerland) is named as a funder in the recent research articles of 20 journals we checked, most often in Atherosclerosis Plus (4 of 140 recent articles). The journals below publish its funded work most often; open a journal for its indexing, review time, reviewer comments and fee waivers.

Journals that publish Novartis Pharmaceuticals Corporation funded research most often

#	Journal	Articles naming it	Indexing	Impact factor*	Median review time
1	Atherosclerosis Plus	4 of 140	SCIE	1.69	n/a
2	Therapeutic Advances in Musculoskeletal Disease	4 of 153	SCIE	3.60	n/a
3	Dermatologic Clinics	3 of 166	SCIE	2.44	n/a
4	European Heart Journal - Quality of Care and Clinical Outcomes	3 of 200	SCIE	3.58	n/a
5	Joint Bone Spine	3 of 200	SCIE	2.59	n/a
6	Bioanalysis	2 of 200	SCIE	2.71	107 days
7	Blood Cells Molecules and Diseases	2 of 91	SCIE	1.98	n/a
8	Drugs - Real World Outcomes	2 of 128	ESCI	2.47	n/a
9	Leukemia Research	2 of 200	SCIE	1.11	n/a
10	Multiple Sclerosis Journal - Experimental Translational and Clinical	2 of 134	ESCI	1.22	n/a
11	Pediatric Nephrology	2 of 200	SCIE	2.27	86 days
12	PET Clinics	2 of 184	ESCI	1.38	n/a
13	Targeted Oncology	2 of 157	SCIE	4.89	100 days
14	Urologic Oncology Seminars and Original Investigations	2 of 200	SCIE	1.51	n/a
15	Anais Brasileiros de Dermatologia	1 of 200	SCIE	1.91	n/a
16	Clinical Transplantation	1 of 200	SCIE	1.78	124 days
17	Expert Review of Anticancer Therapy	1 of 200	SCIE	2.90	77 days
18	Hipertensión y Riesgo Vascular	1 of 43	ESCI	2.00	n/a
19	International Journal of Technology Assessment in Health Care	1 of 200	SCIE	0.70	n/a
20	Physician Assistant Clinics	1 of 167	ESCI	0.14	n/a

"Articles naming" counts the research articles (of up to 200 from the last 24 months) whose funder list names Novartis Pharmaceuticals Corporation. *Impact factor calculated from OpenAlex open data, not the official Clarivate value. Review time: median days from submission to acceptance, from the dates publishers deposit in Crossref.

Funders named alongside Novartis Pharmaceuticals Corporation

Other funders that appear in the same journals. Their pages show where their funded research is published.

National Natural Science Foundation of China National Institutes of Health Pfizer Inc National Cancer Institute Japan Society for the Promotion of Science AstraZeneca PLC Eli Lilly and Company Coordenação de Aperfeiçoamento de Pessoal de Nível Superior European Commission Fundação de Amparo à Pesquisa do Estado de São Paulo National Institute of Arthritis and Musculoskeletal and Skin Diseases Boehringer Ingelheim Bayer Johnson and Johnson National Key Research and Development Program of China National Institute of Diabetes and Digestive and Kidney Diseases

Find a journal for your paper

A journal that often publishes Novartis Pharmaceuticals Corporation funded work is a good start, but the fit with your topic matters most. The free Journal Finder matches your title or abstract to the journals that published the closest papers.

Open the Journal Finder →Check your APC waiver Is my paper ready to submit?

Frequently asked questions

Which journals publish the most Novartis Pharmaceuticals Corporation funded research?

In the recent research articles we checked, the journals that name Novartis Pharmaceuticals Corporation as a funder most often are Atherosclerosis Plus, Therapeutic Advances in Musculoskeletal Disease, Dermatologic Clinics, European Heart Journal - Quality of Care and Clinical Outcomes, Joint Bone Spine. In all, 20 journals name it.

Does publishing in these journals help my Novartis Pharmaceuticals Corporation grant?

These journals already publish work supported by Novartis Pharmaceuticals Corporation, so editors and reviewers know this kind of research. Whether a journal suits your paper still depends on its scope, indexing and review time, shown for each journal in the table.

Does Novartis Pharmaceuticals Corporation pay the article processing charge (APC)?

Many funders pay or reimburse open access fees under their open access policy, but the rules differ by funder and by grant. Check Novartis Pharmaceuticals Corporation's open access policy and your grant terms; for country-based waivers, use the free APC waiver checker.

Where does this data come from?

From the funder information publishers deposit with each article in Crossref. For each journal, ScholarsColab looked at up to 200 research articles from the last 24 months and counted the funders they name. Not every publisher deposits funders, so a journal can be missing.

Source, method and date. Source: the funder information publishers deposit with each article in Crossref. Method: for each journal, ScholarsColab looked at up to 200 research articles from the last 24 months and counted the funders they name; spelling variants of a funder are combined. Updated: 29 October 2026. ScholarsColab is not affiliated with Novartis Pharmaceuticals Corporation or these journals.